{"id":"d67dd979b398","type":"article","url":"https://hartvaat.nl/2026/05/29/lichaamsrondheidsindex-bri-voorspelt-sterfte-bij-nierpatienten-beter-dan-bmi/","title":"Lichaamsrondheidsindex (BRI) voorspelt sterfte bij nierpatiënten beter dan BMI","title_en":"Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox.","category":"chronische nierziekte","category_label":"Nierziekte","professions":["cardioloog","internist"],"tags":[],"journal":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","doi":"10.1093/ndt/gfaf237","source_url":"https://doi.org/10.1093/ndt/gfaf237","authors":["Changyuan Yang","Biyi Liao","Priya Vart","David W Johnson","Ron T Gansevoort","Guobin Su"],"significance":5,"published":"2026-07-27","source_date":"2026-05-29","image":"","kennis":["https://hartvaat.nl/kennis/nierziekte/nierziekte-en-cardiovasculair-risico/","https://hartvaat.nl/kennis/nierziekte/nsaids-en-nierziekte/"],"congress":"","summary_en":"An observational cohort study using NHANES data evaluated the prognostic value of the body roundness index (BRI) compared with BMI and waist circumference in 6,240 patients with chronic kidney disease (CKD). A BRI >10 was independently associated with a significantly higher risk of all-cause mortality (aHR 1.82) and cardiovascular mortality (aHR 2.15), whereas a BMI >30 paradoxically correlated with lower mortality rates. These findings suggest that BRI may offer superior risk stratification over traditional BMI thresholds in CKD populations, particularly among patients under 65 years or with elevated albuminuria.","created":"2026-07-20T01:05:28Z","updated":"2026-08-10T10:38:17Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Een retrospectieve cohortstudie met NHANES-gegevens onderzocht de prognostische waarde van de lichaamsrondheidsindex (BRI) in vergelijking met BMI en tailomvang bij 6240 patiënten met chronische nierziekte (CKD). Een BRI-score >10 ging gepaard met een significant verhoogd risico op all-cause sterfte (aHR 1,82) en cardiovasculaire sterfte (aHR 2,15), terwijl een BMI >30 paradoxaal verbonden was met een lager sterfterisico. Deze bevindingen suggereren dat de BRI een nauwkeuriger risicostratificatie-instrument kan zijn dan BMI bij CKD-patiënten, met name bij jongeren en patiënten met albuminurie.","abstract_original":"BACKGROUND: Body roundness index (BRI), an emerging anthropometric measure, has been shown to outperform body mass index (BMI) in predicting mortality risk in the general population. However, its prognostic value among patients with chronic kidney disease (CKD), where the obesity paradox may exist, remains unknown. METHODS: This observational study utilized data from the National Health and Nutrition Examination Survey. BRI was calculated using waist circumference (WC) and height, whereas BMI was calculated using body weight and height. Restricted cubic splines (RCSs) were applied to determine optimal cut-off points of BRI for all-cause and cardiovascular mortality in patients with CKD. Associations were examined using Cox proportional hazards models adjusted for potential confounders. RESULTS: Over a median follow-up of 6.6 years, 6240 patients with CKD (mean age 63 years, 43% men) were included, with 1922 all-cause and 715 cardiovascular deaths recorded. RCSs demonstrated J-shaped associations between BRI with mortality. A BRI >10 was associated with a significantly increased risk of all-cause {adjusted hazard ratio [aHR] 1.82 [95% confidence interval (CI) 1.34-2.47]} and cardiovascular mortality [aHR 2.15 (95% CI 1.27-3.62)] compared with the reference of 5.9-6.8 and 5.9-6.5, respectively, with dose-response trends (P for trend < .05). A BMI >30 was paradoxically associated with 44% and 40% lower risks of all-cause and cardiovascular mortality compared with the reference of 18.5-25, respectively. A WC >125  was associated with an increased risk of all-cause mortality [aHR 2.17 (95% CI 1.47-3.18)] but not with cardiovascular mortality [aHR 1.83 (95% CI 0.97-3.45)] compared with the reference of 95-105 cm. The associations between BRI >10 and mortality risks were particularly pronounced among younger adults <65 years of age or individuals with elevated albuminuria (P for interaction < .05). CONCLUSIONS: Higher BRI was independently associated with increased all-cause and cardiovascular mortality risk among patients with CKD, offering greater prognostic value for risk stratification than BMI or WC."}